← back to search

Jie Chen

Guangdong Medical College · CN
Area of research
Oncology · Epidemiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Lung Cancer Research Studies, Pancreatic and Hepatic Oncology Research, and Hepatocellular Carcinoma Treatment and Prognosis.
h-index
52
citations
10,888
works
765
NIH funding
primary concept
email

Recent publications

The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study
Annals of Oncology 2025cited by 11position: middledoi
Dysfunction of dendritic cells in tumor microenvironment and immunotherapy
Cancer Communications 2024cited by 54position: firstdoi
Effectiveness of vaginal probiotics Lactobacillus crispatus chen-01 in women with high-risk HPV infection: a prospective controlled pilot study
Aging 2024cited by 39position: middledoi
A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor
Frontiers in Pharmacology 2024cited by 17position: middledoi
Urolithin C suppresses colorectal cancer progression via the AKT/mTOR pathway
Journal of Natural Medicines 2024cited by 10position: middledoi
Nitrite facilitated transformation of halophenols in ice
Water Research 2024cited by 9position: firstdoi
Prognostic value of poly-microorganisms detected by droplet digital PCR and pathogen load kinetics in sepsis patients: a multi-center prospective cohort study
Microbiology Spectrum 2024cited by 7position: middledoi
Multiparametric MRI-based radiomics combined with 3D deep transfer learning to predict cervical stromal invasion in patients with endometrial carcinoma
Abdominal Radiology 2024cited by 6position: middledoi
Inhibiting the CB1 receptor in CIH-induced animal model alleviates colon injury
Applied Microbiology and Biotechnology 2024cited by 6position: middledoi
Long-term safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10%: a European post-authorization study
Immunotherapy 2024cited by 5position: middledoi
Enhancement of CAR‐T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins
Cancer Communications 2023cited by 47position: middledoi
Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II study
International Journal of Gynecological Cancer 2023cited by 26position: middledoi
Outcomes and prognostic factors in initially unresectable hepatocellular carcinoma treated using conversion therapy with lenvatinib and TACE plus PD-1 inhibitors
Frontiers in Oncology 2023cited by 25position: middledoi
Evaluation of Pericardial Thickening and Adhesion Using High-Frequency Ultrasound
Journal of the American Society of Echocardiography 2023cited by 6position: middledoi
Additional file 2 of Single-gene FISH maps and major chromosomal rearrangements in Elymus sibiricus and E. nutans
Figshare 2023cited by 0position: middledoi
Human amniotic epithelial cell-derived extracellular vesicles provide an extracellular matrix-based microenvironment for corneal injury repair
Journal of Tissue Engineering 2022cited by 38position: middledoi
Silencing oncogene cell division cycle associated 5 induces apoptosis and G1 phase arrest of non‐small cell lung cancer cells via p53‐p21 signaling pathway
Journal of Clinical Laboratory Analysis 2022cited by 23position: middledoi
Dominant role of CACNA1D exon mutations for blood pressure regulation
Journal of Hypertension 2022cited by 19position: middledoi
Common variants in genes involved in islet amyloid polypeptide (IAPP) processing and the degradation pathway are associated with T2DM risk: A Chinese population study
Diabetes Research and Clinical Practice 2022cited by 9position: middledoi
Anlotinib in patients with medullary thyroid carcinoma with negative prognostic factors: A sub-analysis based on the ALTER01031 study
Frontiers in Oncology 2022cited by 6position: middledoi
FY-3D Global Active Fire product
Figshare 2022cited by 3position: firstdoi
Additional file 8 of Systematic analysis of CNGCs in cotton and the positive role of GhCNGC32 and GhCNGC35 in salt tolerance
Figshare 2022cited by 0position: middledoi
Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial
Clinical Cancer Research 2021cited by 112position: middledoi
METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma
Molecular Therapy 2020cited by 169position: middledoi
Ultrasound validation of predictive model for central cervical lymph node metastasis in papillary thyroid cancer on <i>BRAF</i>.
2020cited by 10position: contributordoi
Exploration of associations between adverse drug reactions and clinical outcomes in anlotinib treatment against medullary thyroid carcinoma (MTC): A subgroup analysis based on the ALTER01031 trial.
Journal of Clinical Oncology 2020cited by 0position: middledoi
Influence of Eastern Cooperative Oncology Group performance status (ECOG PS), tumor size and age on patient outcomes after anlotinib treatment: A subgroup analysis based on ALTER01031 trial for medullary thyroid carcinoma (MTC).
Journal of Clinical Oncology 2020cited by 0position: middledoi
The Prognostic Value of aspartate aminotransferase to lymphocyte ratio and systemic immune-inflammation index for Overall Survival of Hepatocellular Carcinoma Patients Treated with palliative Treatments
Journal of Cancer 2019cited by 63position: middledoi
Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer – A subgroup analysis of the pivotal NAPOLI-1 trial
Journal of Geriatric Oncology 2019cited by 27position: middledoi
The Predictive Value of Albumin-to-Alkaline Phosphatase Ratio for Overall Survival of Hepatocellular Carcinoma Patients Treated with Trans-Catheter Arterial Chemoembolization Therapy
Journal of Cancer 2018cited by 37position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jiewu Zhang · Harbin Medical University4 papers (2020–2022)Xiangqian Zheng · Center for Cancer Research4 papers (2020–2022)Zhengang Xu · Nanchang University4 papers (2020–2022)Ruochuan Cheng · Jilin University4 papers (2020–2022) · 4 papers (2020–2022)Ying Cheng · Changzhi University4 papers (2020–2022)Jingqiang Zhu · Sichuan University4 papers (2020–2022)Yihebali Chi · Chinese Academy of Medical Sciences & Peking Union Medical College4 papers (2020–2022)Zhuming Guo · Nanfang Hospital4 papers (2020–2022)Dapeng Li · Jiangsu University4 papers (2020–2022)Qiang Li · Nanjing Medical University4 papers (2020–2022)Ming Gao · Chinese Academy of Forestry3 papers (2020–2022)Hui Liu · Harbin Medical University3 papers (2020–2022)Qu Lin · Sun Yat-sen University3 papers (2017–2019)Zhan‐Hong Chen · South China Agricultural University3 papers (2017–2019)Min Dong · Jiangsu University3 papers (2017–2019)Jianwu Qin · Zhengzhou University3 papers (2020–2022)Jing‐Yun Wen · Sun Yat-sen University3 papers (2017–2019)Minghua Ge · Wenzhou Medical University2 papers (2020–2020)Xiangyuan Wu · Sun Yat-sen University2 papers (2017–2019)